Oleuropein / P21 Cancer Research Results

OLE, Oleuropein: Click to Expand ⟱

Features:

Oleocanthal is essentially found ONLY in: Fresh, unrefined extra-virgin olive oil (EVOO)
It is part of the pungent, throat-stinging phenolic fraction that disappears in refined oils.

Oleuropein (OLEU) — a secoiridoid polyphenol from olive leaf and olive fruit/extra-virgin olive oil; major in-vivo related phenolic is hydroxytyrosol (via hydrolysis/metabolism). Sources: olive leaf extract (standardized to oleuropein), EVOO phenolics.

Primary mechanisms (conceptual rank):
1) Redox modulation (ROS ↓ in normal tissue; stress/hormesis; NRF2 ↑ context-dependent)
2) Anti-inflammatory transcription suppression (NF-κB ↓)
3) Anti-proliferative signaling in cancer models (PI3K/AKT/mTOR ↓; MAPK modulation; apoptosis ↑; model-dependent)
4) Anti-angiogenic / hypoxia coupling (HIF-1α/VEGF ↓; model-dependent)

Bioavailability / PK relevance: Human data show absorption/metabolism after oral olive leaf extract; circulating forms are largely metabolites (and hydroxytyrosol-related), with limited free parent compound exposure. :contentReference[oaicite:0]{index=0}

In-vitro vs oral exposure: Many direct “anticancer” cytotoxic effects occur at micromolar concentrations that may exceed typical systemic exposure from supplements/foods (high concentration only for direct tumor cytotoxicity in many models). :contentReference[oaicite:1]{index=1}

Clinical evidence status: Nutraceutical/food bioactive with human data mainly for cardiometabolic/inflammation endpoints; oncology evidence largely preclinical/adjunct-hypothesis (no oncology approval).

Also available as a supplement usually labeled as Olive Leaf Extract. (20-50% concentrations)
- commonly used in CSC (Cancer Stem Cell) research.
Main CSC mechanisms:
-Inhibits Wnt/β-catenin — a core CSC survival pathway
-↓ALDH (Reduces ALDH-high CSC subpopulations)
-downregulates stemness geens: SOX2/OCT4/Nanog → reduced sphere formation/self-renewal.

Oleuropein — Cancer vs Normal Cell Pathway Map

Rank	Pathway / Axis	Cancer Cells	Normal Cells	TSF	Primary Effect	Notes / Interpretation
1	ROS	↑ or ↓ (dose-/model-dependent)	↓ (primary)	P/R	Redox reprogramming	Normal tissue: antioxidant/lipid-peroxidation reduction common. Cancer: higher exposures can induce stress/apoptosis; direction varies by model and co-stressors.
2	NF-κB / cytokine programs	↓	↓	R/G	Anti-inflammatory / anti-survival transcription	Commonly reported mechanism for oleuropein/olive phenolics. :contentReference[oaicite:3]{index=3}
3	NRF2 (protective vs resistance role)	↔ / ↑ (context-dependent)	↑	R/G	Antioxidant gene induction	NRF2 modulation is frequently discussed for olive polyphenols; in cancer contexts can be double-edged (cytoprotection/resistance). :contentReference[oaicite:4]{index=4}
4	PI3K/AKT/mTOR	↓ (model-dependent; high concentration only)	↔	R/G	Reduced anabolic survival signaling	Reported across cancer models and olive phenolic literature; translation depends on exposure. :contentReference[oaicite:5]{index=5}
5	Intrinsic apoptosis (Bax↑/Bcl-2↓; caspases)	↑ (model-dependent; high concentration only)	↔	R/G	Mitochondrial apoptosis	Common downstream endpoint in preclinical cancer work; often coupled to redox and PI3K/AKT shifts. :contentReference[oaicite:6]{index=6}
6	HIF-1α / VEGF (angiogenesis)	↓ (model-dependent)	↔	G	Reduced hypoxia-adaptation / vascular support	Typically secondary; varies strongly by model and readout.
7	Cell cycle checkpoints	↓ proliferation (model-dependent)	↔	G	Cytostatic growth restraint	Often reported as G0/G1 or G2/M arrest in vitro; exposure gap is common. :contentReference[oaicite:7]{index=7}
8	Ferroptosis	↔ (limited / context-dependent)	↔	R/G	Not canonical	Olive phenolics can influence lipid peroxidation, but a consistent oleuropein-driven ferroptosis program is not a core claim in the main reviews.
9	Ca²⁺ signaling	↔	↔	P/R	No primary role	Include only if a specific ER/mitochondrial stress model measures Ca²⁺ endpoints.
10	Clinical Translation Constraint	↓ (constraint)	↓ (constraint)	—	Metabolite-dominant exposure	Human absorption/metabolism exists, but many tumor-directed effects rely on higher in-vitro exposures; extract standardization and formulation matter. :contentReference[oaicite:8]{index=8}

TSF legend: P: 0–30 min; R: 30 min–3 hr; G: >3 hr

Oleuropein — AD relevance: Oleuropein/olive leaf phenolics show neuroprotection in models via oxidative- and heat-shock/proteostasis stress responses, with reported reduction of Aβ and tau proteotoxicity in preclinical systems; human AD disease-modifying evidence is not established.

Primary mechanisms (conceptual rank):
1) ↓ Oxidative stress (ROS ↓; lipid peroxidation ↓; NRF2-linked defense ↑)
2) ↓ Neuroinflammation (NF-κB tone ↓)
3) Proteostasis support (heat-shock/stress-response pathways; context-dependent)
4) Aβ/tau proteotoxicity ↓ (preclinical)

Bioavailability / PK relevance: Human absorption/metabolism supports systemic exposure mainly as metabolites; brain relevance likely chronic/adaptive. :contentReference[oaicite:9]{index=9}

Clinical evidence status: Predominantly preclinical for AD mechanisms; limited AD-specific clinical endpoint evidence.

Oleuropein — AD / Neurodegeneration Pathway Map

Rank	Pathway / Axis	Cells	TSF	Primary Effect	Notes / Interpretation
1	ROS / lipid peroxidation	↓	P/R	Reduced oxidative burden	Central neuroprotection rationale for olive polyphenols (includes oleuropein/hydroxytyrosol pathways). :contentReference[oaicite:11]{index=11}
2	NRF2 axis	↑ (context-dependent)	R/G	Stress-defense upshift	NRF2 modulation is repeatedly discussed for olive polyphenols in cognition-related health framing. :contentReference[oaicite:12]{index=12}
3	Neuroinflammation (NF-κB / cytokines)	↓	R/G	Lower inflammatory stress	Often paired with antioxidant effects; model-dependent magnitude.
4	Proteostasis / heat-shock stress responses	↑ (supportive)	R/G	Improved handling of misfolded proteins	Oleuropein-rich olive leaf extract reduced Aβ and tau proteotoxicity via oxidative/heat-shock stress regulation in a C. elegans model. :contentReference[oaicite:13]{index=13}
5	Aβ / tau proteotoxicity	↓ (preclinical)	G	Reduced pathology-linked toxicity	Evidence is stronger in models than in biomarker-confirmed human AD studies. :contentReference[oaicite:14]{index=14}
6	Ca²⁺ homeostasis / excitotoxic vulnerability	↔ / stabilized (indirect)	P/R	Supportive (secondary)	Typically secondary to mitochondrial/redox support unless a study explicitly measures Ca²⁺ endpoints.
7	Clinical Translation Constraint	↓ (constraint)	—	Preclinical-dominant AD evidence	Most AD-relevant mechanisms are model-based; human AD efficacy endpoints remain limited. :contentReference[oaicite:15]{index=15}

TSF legend: P: 0–30 min; R: 30 min–3 hr; G: >3 hr

P21, P21: Click to Expand ⟱

Source:

Type: Proapototic

cyclin-dependent kinase inhibitor p21 (also known as p21 WAF1/Cip1) promotes cell cycle arrest in response to many stimuli.
P21 is a cyclin-dependent kinase inhibitor that plays a crucial role in regulating the cell cycle. It is encoded by the CDKN1A gene and is a key player in the cellular response to stress, including DNA damage.
P21 is often considered a tumor suppressor because its expression is upregulated in response to p53 activation, a well-known tumor suppressor protein. When DNA damage occurs, p53 can activate the transcription of the CDKN1A gene, leading to increased levels of P21, which helps prevent the proliferation of damaged cells.
In many cancers, the p53 pathway is disrupted, leading to decreased levels of P21. p21 is a apoptotic marker protein.
Cell cycle arrest gene p21

Scientific Papers found: Click to Expand⟱

4630-

OLE,

Targeting resistant breast cancer stem cells in a three-dimensional culture model with oleuropein encapsulated in methacrylated alginate microparticles

in-vitro,

BC,

Bcl-2↓, BAX↑, Casp3↑, Casp9↑, Vim↓, Slug↓, E-cadherin↑, CSCs↓, P21↑, survivin↝, OCT4↑, Nanog↑, SOX4↑,

4643-

OLE,

HT,

Use of Oleuropein and Hydroxytyrosol for Cancer Prevention and Treatment: Considerations about How Bioavailability and Metabolism Impact Their Adoption in Clinical Routine

Review,

Var,

TumCCA↑, Apoptosis↑, ER Stress↑, UPR↑, CHOP↑, ROS↑, Bcl-2↓, NOX4↑, Hif1a↓, MMP2↓, MMP↓, VEGF↓, Akt↓, NF-kB↓, p65↓, SIRT3↓, mTOR↓, Catalase↓, SOD2↓, FASN↓, STAT3↓, HDAC2↓, HDAC3↓, BAD↑, BAX↑, Bak↑, Casp3↑, Casp9↑, PARP↑, P53↑, P21↑, p27↑, Half-Life↝, BioAv↓, BioAv↓, selectivity↑, RadioS↑, *ROS↓, *GSH↑, *MDA↓, *SOD↑, *Catalase↑, *NRF2↑, *chemoP↑, *Inflam↓, PPARγ↑,

Showing Research Papers: 1 to 2 of 2

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2

Pathway results for Effect on Cancer / Diseased Cells:

Pathway results for Effect on Normal Cells:

Redox & Oxidative Stress ⓘ

Catalase↑, 1, GSH↑, 1, MDA↓, 1, NRF2↑, 1, ROS↓, 1, SOD↑, 1,

Immune & Inflammatory Signaling ⓘ

Inflam↓, 1,

Functional Outcomes ⓘ

chemoP↑, 1,
Total Targets: 8

Scientific Paper Hit Count for: P21, P21

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:375  Target#:234  State#:%  Dir#:2
  wNotes=0  sortOrder:rid,rpid

Oleuropein / P21 Cancer Research Results

Oleuropein — Cancer vs Normal Cell Pathway Map

Oleuropein — AD / Neurodegeneration Pathway Map

Pathway results for Effect on Cancer / Diseased Cells:

Redox & Oxidative Stress ⓘ

Mitochondria & Bioenergetics ⓘ

Core Metabolism/Glycolysis ⓘ

Cell Death ⓘ

Protein Folding & ER Stress ⓘ

DNA Damage & Repair ⓘ

Cell Cycle & Senescence ⓘ

Proliferation, Differentiation & Cell State ⓘ

Migration ⓘ

Angiogenesis & Vasculature ⓘ

Immune & Inflammatory Signaling ⓘ

Drug Metabolism & Resistance ⓘ

Pathway results for Effect on Normal Cells:

Redox & Oxidative Stress ⓘ

Immune & Inflammatory Signaling ⓘ

Functional Outcomes ⓘ

Home Page